Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -59.01% | -10.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 81.50% | -10.74% | |||
| Cost of Revenue | 441.44% | -18.07% | |||
| Gross Profit | 2.02% | -8.94% | |||
| SG&A Expenses | 1.25% | -25.70% | |||
| Depreciation & Amortization | 0.07% | -8.24% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.68% | -12.91% | |||
| Operating Income | -9.21% | 12.96% | |||
| Income Before Tax | -271.73% | 8.61% | |||
| Income Tax Expenses | 59.39% | -9,584.55% | |||
| Earnings from Continuing Operations | -337.35% | 23.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -337.35% | 23.85% | |||
| EBIT | -9.21% | 12.96% | |||
| EBITDA | -9.57% | 13.13% | |||
| EPS Basic | -193.24% | 33.46% | |||
| Normalized Basic EPS | 29.87% | 23.49% | |||
| EPS Diluted | -184.74% | 31.47% | |||
| Normalized Diluted EPS | 29.87% | 23.49% | |||
| Average Basic Shares Outstanding | 49.14% | 14.44% | |||
| Average Diluted Shares Outstanding | 49.14% | 14.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||